tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GB:0QGJ Stock Latest News

Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
Press ReleasesMedigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
14d ago
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
PremiumPress Releases
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
20d ago
Medigene Reports Results of Annual General Meeting
PremiumPress Releases
Medigene Reports Results of Annual General Meeting
23d ago
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
PremiumPress Releases
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
26d ago
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
PremiumPress Releases
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
2M ago
Medigene’s Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
PremiumPress ReleasesMedigene’s Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
2M ago
Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
PremiumPress Releases
Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
2M ago
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
PremiumPress Releases
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
2M ago
Medigene to Present at Upcoming Conferences
PremiumPress Releases
Medigene to Present at Upcoming Conferences
2M ago
Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor
PremiumPress Releases
Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor
3M ago
Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
PremiumPress Releases
Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
3M ago
Medigene AG reports Financial Results and Business Update for Q1 2024
PremiumPress Releases
Medigene AG reports Financial Results and Business Update for Q1 2024
3M ago
Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
PremiumPress ReleasesMedigene presents streamlined 6-day, high stemness TCR-T therapy production process
3M ago
Medigene to Present at Upcoming Scientific Conferences
PremiumPress Releases
Medigene to Present at Upcoming Scientific Conferences
3M ago
Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024
PremiumPress Releases
Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024
3M ago
Medigene AG Secures European Patent for its iM-TCR Technology
PremiumPress Releases
Medigene AG Secures European Patent for its iM-TCR Technology
3M ago
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
4M ago
Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
PremiumPress Releases
Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
4M ago
Medigene AG to report full year 2023 financial results on March 28, 2024
PremiumPress Releases
Medigene AG to report full year 2023 financial results on March 28, 2024
4M ago
Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting
PremiumPress ReleasesMedigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting
4M ago
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
PremiumPress Releases
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
5M ago
Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies
PremiumPress Releases
Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >